Sponsor or institution
Clinical trials and research at N.N. Alexandrov National Cancer Centre
As of November 12, 2026, Find a Trial lists 4 clinical trials run by N.N. Alexandrov National Cancer Centre that are recruiting, in Belarus. By phase: Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Academic anti-CD19 CAR-T for relapsed or refractory large B‑cell lymphoma | — | Lyasny, Minsk Oblast | Recruiting | Apr 13, 2026 |
| PD-1 versus PD-L1 immunotherapy combined with chemotherapy, with or without bevacizumab, for advanced cervical cancer. | Phase 2/3 | Minsk, Lesnoy | Recruiting | Mar 16, 2026 |
| PARP inhibitor with or without an angiogenesis inhibitor for HRD advanced ovarian, fallopian-tube, or primary peritoneal cancer | Phase 2/3 | Minsk, Lesnoy | Recruiting | Mar 16, 2026 |
| Limited versus extended pelvic lymph node removal during radical prostatectomy for localized or locally advanced prostate cancer | — | Lyasny, Minsk Oblast | Recruiting | Dec 30, 2025 |
All recruiting trials (4)
-
Academic anti-CD19 CAR-T for relapsed or refractory large B‑cell lymphoma
This project tests whether a locally manufactured anti‑CD19 CAR‑T cell therapy works and is safe for adults whose large B‑cell lymphoma has relapsed or not responded to prior treatment.
-
PD-1 versus PD-L1 immunotherapy combined with chemotherapy, with or without bevacizumab, for advanced cervical cancer.
This trial tests whether giving PD-1 or PD-L1 immunotherapy alongside chemotherapy, with or without bevacizumab, helps adults with metastatic, persistent, or recurrent cervical cancer.
-
PARP inhibitor with or without an angiogenesis inhibitor for HRD advanced ovarian, fallopian-tube, or primary peritoneal cancer
This trial will test whether adding the angiogenesis drug bevacizumab to a PARP inhibitor helps people with homologous recombination deficient (HRD) stage III–IV ovarian, fallopian-tube, or primary peritoneal cancer.
-
Limited versus extended pelvic lymph node removal during radical prostatectomy for localized or locally advanced prostate cancer
This study will see if removing fewer versus more pelvic lymph nodes during prostate removal helps men with localized or locally advanced prostate cancer.
Quick answers
How many clinical trials run by N.N. Alexandrov National Cancer Centre are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Belarus. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.